Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ALFoNS - Growth and Metabolism in Infants Fed Protein-reduced, Alpha-lactalbumin Enriched Formula Compared to Breastfed Infants

NCT02410057 is registered in ClinicalTrials.gov with Skane University Hospital as lead sponsor.

NCT NCT02410057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02410057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ALFoNS - Growth and Metabolism in Infants Fed Protein-reduced, Alpha-lactalbumin Enriched Formula Compared to Breastfed Infants
Lead sponsor
Skane University Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2014
Completion date
December 31, 2024
Enrollment
328 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

growth, infection, sleep